Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
4926
PUT
DELISTED
Juno Therapeutics, Inc.
JUNO
| $513K | ﹤0.01% |
23,100
+15,100
| +189% | +$324K |
|
4927
eHealth
EHTH
$42.2M
| $512K | ﹤0.01% |
42,541
-7,192
| -14% | -$83.2K |
|
4928
1-800-Flowers.com
FLWS
$245M
| $511K | ﹤0.01% |
50,138
+702
| +1% | +$7.04K |
|
4929
CALL
PENN Entertainment
PENN
$2.73B
| $511K | ﹤0.01% |
27,700
+22,300
| +413% | +$327K |
|
|
HTB
4930
HomeTrust Bancshares
HTB
$862M
| $511K | ﹤0.01% |
21,763
+3,202
| +17% | +$78.6K |
|
|
SPWR
4931
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $511K | ﹤0.01% |
127,963
-7,940
| -6% | -$37.3K |
|
|
SNC
4932
DELISTED
State National Companies, Inc.
SNC
| $511K | ﹤0.01% |
35,514
-37,804
| -52% | -$525K |
|
|
PX
4933
CALL
DELISTED
Praxair Inc
PX
| $510K | ﹤0.01% |
4,300
-5,200
| -55% | -$611K |
|
|
LM
4934
CALL
DELISTED
Legg Mason, Inc.
LM
| $509K | ﹤0.01% |
14,100
-600
| -4% | -$20.8K |
|
|
BIVV
4935
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $509K | ﹤0.01% |
+9,350
| New | +$461K |
|
|
KATE
4936
PUT
DELISTED
Kate Spade & Company
KATE
| $509K | ﹤0.01% |
21,900
-17,200
| -44% | -$360K |
|
4937
VanEck India Growth Leaders ETF
GLIN
$95.9M
| $508K | ﹤0.01% |
9,593
-4,217
| -31% | -$200K |
|
4938
CALL
Golar LNG
GLNG
$4.98B
| $508K | ﹤0.01% |
18,200
-473,300
| -96% | -$12.7M |
|
|
ORBK
4939
DELISTED
Orbotech Ltd
ORBK
| $507K | ﹤0.01% |
15,736
-25,823
| -62% | -$834K |
|
|
GUID
4940
DELISTED
Guidance Software, Inc.
GUID
| $506K | ﹤0.01% |
85,692
+26,541
| +45% | +$181K |
|
4941
CALL
Diana Shipping
DSX
$297M
| $505K | ﹤0.01% |
156,478
+122,293
| +358% | +$344K |
|
4942
CALL
ProShares Ultra Financials
UYG
$824M
| $505K | ﹤0.01% |
15,600
-900
| -5% | -$29.3K |
|
|
ZAGG
4943
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $505K | ﹤0.01% |
70,159
+46,458
| +196% | +$312K |
|
|
CGI
4944
DELISTED
Celadon Group Inc
CGI
| $505K | ﹤0.01% |
77,083
+26,039
| +51% | +$213K |
|
4945
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$437M
| $502K | ﹤0.01% |
5,800
-161,800
| -97% | -$13.7M |
|
4946
PUT
Zebra Technologies
ZBRA
$13.7B
| $502K | ﹤0.01% |
5,500
+2,000
| +57% | +$173K |
|
|
BRCD
4947
PUT
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $502K | ﹤0.01% |
40,200
-24,900
| -38% | -$309K |
|
4948
Seres Therapeutics
MCRB
$45.2M
| $501K | ﹤0.01% |
2,221
+443
| +25% | +$89.9K |
|
4949
TG Therapeutics
TGTX
$7.98B
| $501K | ﹤0.01% |
43,020
+26,001
| +153% | +$187K |
|
4950
PUT
Nu Skin
NUS
$247M
| $500K | ﹤0.01% |
9,000
-26,400
| -75% | -$1.36M |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.